STENOCARE terminates license agreement with CannTrust and prepares for new partnerships
STENOCARE A/S (“STENOCARE”) hereby informs that the company has terminated its license agreement with CannTrust Holding Inc. (“CannTrust”) with immediate effect due to CannTrust’s inability to deliver on critical elements in the agreement. With this, STENOCARE is now free to engage with new partners.On September 17th, 2019, it was announced that Health Canada had suspended CannTrust’s license to produce and sell medical cannabis. This only adds formal evidence to the fact that CannTrust cannot fulfil their obligations to STENOCARE. The obligations include, but are not limited to, the